US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Ashland

50.81

+0.89001.78%

Post-market: 50.810.00000.00%19:27 EDT

Volume:426.30K

Turnover:21.64M

Market Cap:2.33B

PE:-3.36

High:51.21

Open:49.35

Low:49.30

Close:49.92

52wk High:65.65

52wk Low:45.21

Shares:45.76M

Float Shares:41.77M

Volume Ratio:0.51

T/O Rate:1.02%

Dividend:1.65

Dividend Rate:3.25%

EPS(TTM):-15.1257

EPS(LYR):-18.3696

ROE:-29.98%

ROA:2.09%

PB:1.24

PE(LYR):-2.77

Loading ...

Overview Company News Filings

Assessing Ashland (ASH) Valuation After Recent Share Price Weakness And Perceived 27.3% Discount

Simply Wall St.

Ashland Is Maintained at Buy by Argus Research

Ashland Inc : Argus Research Cuts Target Price to $56 From $70

THOMSON REUTERS

Ashland Implements Pricing Actions Globally Due to Market Volatility Amid Middle East Conflict

MT Newswires Live

Ashland to implement global pricing actions across product portfolio to manage energy, raw material and logistics volatility

Press Release: BioLineRx Reports 2025 Financial Results and Provides Corporate Update

Ashland Inc - Pricing Actions to Vary by Product and Region

THOMSON REUTERS

Ashland Implements Pricing Actions Across Product Portfolio in Response to Market Volatility

THOMSON REUTERS

Cellectis Reports Full Year 2025 Financial Results and Provides a Business Update

Press Release: SELLAS Life Sciences Reports Full Year 2025 Financial Results and Provides Corporate Update

Belief BioMed announced BBM-H901 (Dalnacogene Ponparvovec Injection), China's first hemophilia B gene therapy, was officially approved in Macao, China

Press Release: Marker Therapeutics Reports Year-End 2025 Corporate and Financial Results

Ashland CFO William Whitaker to join fireside chat at Gabelli Funds Specialty Chemicals Symposium

Ashland (ASH) Is Down 7.7% After Tightening 2026 Outlook And Detailing New Cost Savings Targets

Simply Wall St.

Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

Molecular Partners Reports Highlights and Financial Results for Full Year 2025

Press Release: Prelude Therapeutics Reports Full Year 2025 Financial Results and Provides Program Outlook for 2026

Legend Biotech Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights

Press Release: Climb Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

TScan Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ASH/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ASH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ASH\",,,,,undefined,":{"symbol":"ASH","market":"US","secType":"STK","nameCN":"Ashland","latestPrice":50.81,"timestamp":1774382400000,"preClose":49.92,"halted":0,"volume":426301,"hourTrading":{"tag":"盘后","latestPrice":50.81,"preClose":50.81,"latestTime":"19:27 EDT","volume":12372,"amount":628643.44,"timestamp":1774394820398,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.01782852564102565,"floatShares":41773472,"shares":45762099,"eps":-15.125683,"marketStatus":"Not Yet Opened","change":0.89,"latestTime":"03-24 16:00:00 EDT","open":49.35,"high":51.21,"low":49.3,"amount":21636827.963014,"amplitude":0.038261,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-15.125683,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774425600000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":49.92,"dividendRate":0.032478,"preHourTrading":{"tag":"盘前","latestPrice":50.9,"preClose":49.92,"latestTime":"09:26 EDT","volume":137,"amount":6866.629608,"timestamp":1774358805980,"change":0.98,"changeRate":0.019631,"amplitude":0.031651},"postHourTrading":{"tag":"盘后","latestPrice":50.81,"preClose":50.81,"latestTime":"19:27 EDT","volume":12372,"amount":628643.44,"timestamp":1774394820398,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.511522,"impliedVol":0.2526,"impliedVolPercentile":0.036},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ASH\",,,,,undefined,":{"symbol":"ASH","floatShares":41773472,"roa":"2.09%","roe":"-29.98%","lyrEps":-18.369565,"volumeRatio":0.511522,"shares":45762099,"dividePrice":1.6502,"high":51.21,"amplitude":0.038261,"preClose":49.92,"low":49.3,"week52Low":45.21,"pbRate":"1.24","psRate":"1.29","week52High":65.645,"institutionHeld":0.8513,"latestPrice":50.81,"eps":-15.125683,"divideRate":0.032478,"volume":426301,"delay":0,"ttmEps":-15.125683,"open":49.35,"prevYearClose":58.67,"prevWeekClose":48.81,"prevMonthClose":62.36,"prevQuarterClose":58.67,"fiveDayClose":51.49,"twentyDayClose":64.09,"sixtyDayClose":59.39,"dividendPayoutRate":0.4581065874857458,"dividendFrequency":"Q","dividendGrowthYears":7,"dividendGrowthRate":0.037974683544303826,"fiveYearAvgDividendRate":0.01932116730388857},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ASH\",params:#limit:5,,,undefined,":[{"date":"2026-02-27","symbol":"ASH","amount":0.415,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-01","defaultRemindTime":1772202600000,"name":"Ashland","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-15","payableDate":"2026-03-01","currency":"USD","dateTimestamp":1772168400000,"payDate":"2026-03-15"},{"market":"US","date":"2026-02-02","symbol":"ASH","fiscalQuarterEnding":"2025/12","expectedEps":0.23,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1770008400000,"reportTimeType":"post","actualEps":0.26},{"date":"2025-12-01","symbol":"ASH","amount":0.415,"announcedDate":"2025-11-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-01","defaultRemindTime":1764599400000,"name":"Ashland","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-15","payableDate":"2025-12-01","currency":"USD","dateTimestamp":1764565200000,"payDate":"2025-12-15"},{"market":"US","date":"2025-11-04","symbol":"ASH","fiscalQuarterEnding":"2025/09","expectedEps":1.17,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":1.08},{"date":"2025-08-29","symbol":"ASH","amount":0.415,"announcedDate":"2025-08-08","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-01","defaultRemindTime":1756474200000,"name":"Ashland","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-15","payableDate":"2025-09-01","currency":"USD","dateTimestamp":1756440000000,"payDate":"2025-09-15"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ASH\",market:\"US\",,,undefined,":[{"executeDate":"2016-06-01","recordDate":"2016-06-03","paymentDate":"2016-06-15","value":0.39,"currency":"USD"},{"executeDate":"2016-08-17","recordDate":"2016-08-19","paymentDate":"2016-09-15","value":0.39,"currency":"USD"},{"executeDate":"2016-11-29","recordDate":"2016-12-01","paymentDate":"2016-12-15","value":0.39,"currency":"USD"},{"executeDate":"2017-02-27","recordDate":"2017-03-01","paymentDate":"2017-03-15","value":0.39,"currency":"USD"},{"executeDate":"2017-05-30","recordDate":"2017-06-01","paymentDate":"2017-06-15","value":0.225,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ASH\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2308,"buy":0.4615,"hold":0.3077,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4615,"analysts":13,"updateTime":1765857600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ASH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ASH","date":"2026-03-23","current":-3.359187,"percent":0.1715,"low":-152.607239,"twenty":-2.870292,"median":17.87218,"eighty":27.96152,"high":41.666396,"avg":6.968592,"sd":34.706426,"marketCap":2233648052},"quantilePoints":[{"date":"2021-03-26","current":-11.298674,"twenty":-41.685517,"median":16.565507,"eighty":45.060758,"marketCap":5468558354},{"date":"2021-04-01","current":-11.32625,"twenty":-41.685517,"median":16.544159,"eighty":45.032615,"marketCap":5481905179},{"date":"2021-04-09","current":-11.130711,"twenty":-41.766144,"median":16.513421,"eighty":45.025182,"marketCap":5387264054},{"date":"2021-04-16","current":-11.373882,"twenty":-41.766144,"median":16.49824,"eighty":44.88663,"marketCap":5504958787},{"date":"2021-04-23","current":-11.615799,"twenty":-41.766144,"median":16.458163,"eighty":44.798223,"marketCap":5622046845},{"date":"2021-04-30","current":37.652621,"twenty":-41.766144,"median":16.458163,"eighty":44.763306,"marketCap":5233714269},{"date":"2021-05-07","current":38.556703,"twenty":-41.766144,"median":16.48927,"eighty":44.763306,"marketCap":5359381692},{"date":"2021-05-14","current":38.897371,"twenty":-41.766144,"median":16.508117,"eighty":44.763306,"marketCap":5406734634},{"date":"2021-05-21","current":38.897371,"twenty":-41.766144,"median":16.532217,"eighty":44.763306,"marketCap":5406734634},{"date":"2021-05-28","current":41.421813,"twenty":-41.766144,"median":16.539302,"eighty":44.763306,"marketCap":5757632076},{"date":"2021-06-04","current":41.177231,"twenty":-41.766144,"median":16.551203,"eighty":44.763306,"marketCap":5723635092},{"date":"2021-06-11","current":40.923913,"twenty":-41.766144,"median":16.551203,"eighty":44.763306,"marketCap":5688423930},{"date":"2021-06-18","current":38.067538,"twenty":-41.766144,"median":16.551203,"eighty":44.763306,"marketCap":5291387724},{"date":"2021-06-25","current":38.72267,"twenty":-41.766144,"median":16.559996,"eighty":44.763306,"marketCap":5382451074},{"date":"2021-07-02","current":38.32959,"twenty":-41.766144,"median":16.589527,"eighty":44.763306,"marketCap":5327813064},{"date":"2021-07-09","current":38.399471,"twenty":-41.766144,"median":16.609898,"eighty":44.763306,"marketCap":5337526488},{"date":"2021-07-16","current":37.713766,"twenty":-41.766144,"median":16.609898,"eighty":44.763306,"marketCap":5242213515},{"date":"2021-07-23","current":38.233504,"twenty":-41.766144,"median":16.609898,"eighty":44.763306,"marketCap":5314457106},{"date":"2021-07-30","current":28.544675,"twenty":-41.766144,"median":16.63409,"eighty":44.763306,"marketCap":5166586254},{"date":"2021-08-06","current":28.329928,"twenty":-41.766144,"median":16.642592,"eighty":44.763306,"marketCap":5127716909},{"date":"2021-08-13","current":29.118455,"twenty":-41.766144,"median":16.707431,"eighty":44.763306,"marketCap":5270440286},{"date":"2021-08-20","current":28.051427,"twenty":-41.766144,"median":16.798988,"eighty":44.763306,"marketCap":5077308227},{"date":"2021-08-27","current":29.259383,"twenty":-41.766144,"median":16.876011,"eighty":44.763306,"marketCap":5295948294},{"date":"2021-09-03","current":31.51759,"twenty":-41.685517,"median":16.928602,"eighty":44.762757,"marketCap":5704683753},{"date":"2021-09-10","current":31.051184,"twenty":-41.685517,"median":16.94157,"eighty":44.762757,"marketCap":5620264394},{"date":"2021-09-17","current":30.272724,"twenty":-41.685517,"median":16.987677,"eighty":44.762757,"marketCap":5479363017},{"date":"2021-09-24","current":31.121649,"twenty":-41.685517,"median":16.987677,"eighty":44.762757,"marketCap":5633018398},{"date":"2021-10-01","current":30.59149,"twenty":-41.685517,"median":19.684212,"eighty":44.762757,"marketCap":5537059701},{"date":"2021-10-08","current":31.071317,"twenty":-41.685517,"median":19.787677,"eighty":44.762757,"marketCap":5623908395},{"date":"2021-10-15","current":32.124923,"twenty":-41.685517,"median":19.83941,"eighty":44.762757,"marketCap":5814611120},{"date":"2021-10-22","current":32.826209,"twenty":-41.685517,"median":19.917009,"eighty":44.762757,"marketCap":5941543826},{"date":"2021-10-29","current":32.21552,"twenty":-41.604889,"median":19.999764,"eighty":44.762207,"marketCap":5831009125},{"date":"2021-11-05","current":32.916806,"twenty":-41.604889,"median":20.15896,"eighty":44.762207,"marketCap":5957941831},{"date":"2021-11-12","current":29.342491,"twenty":-41.604889,"median":20.28364,"eighty":44.762207,"marketCap":6455347984},{"date":"2021-11-19","current":30.162391,"twenty":-41.604889,"median":20.500749,"eighty":44.762207,"marketCap":6635726039},{"date":"2021-11-26","current":26.923508,"twenty":-41.604889,"median":20.528215,"eighty":44.762207,"marketCap":5923171764},{"date":"2021-12-03","current":26.411959,"twenty":-41.604889,"median":20.552965,"eighty":44.762207,"marketCap":5810630932},{"date":"2021-12-10","current":27.165993,"twenty":-41.604889,"median":20.676932,"eighty":44.762207,"marketCap":5976518382},{"date":"2021-12-17","current":26.837476,"twenty":-41.604889,"median":20.708356,"eighty":44.762207,"marketCap":5904244736},{"date":"2021-12-23","current":26.982334,"twenty":-41.604889,"median":20.728755,"eighty":44.762207,"marketCap":5936113430},{"date":"2021-12-31","current":27.848893,"twenty":-41.604889,"median":20.764302,"eighty":44.762207,"marketCap":6126756513},{"date":"2022-01-07","current":26.876277,"twenty":-41.524262,"median":20.796751,"eighty":44.761658,"marketCap":5912780993},{"date":"2022-01-14","current":27.341891,"twenty":-41.524262,"median":20.868148,"eighty":44.761658,"marketCap":6015216083},{"date":"2022-01-21","current":25.013821,"twenty":-41.524262,"median":20.917445,"eighty":44.761658,"marketCap":5503040636},{"date":"2022-01-28","current":24.677544,"twenty":-41.524262,"median":20.980342,"eighty":44.761658,"marketCap":5429059738},{"date":"2022-02-04","current":25.572734,"twenty":-41.443634,"median":21.023702,"eighty":44.761108,"marketCap":5421419569},{"date":"2022-02-11","current":25.553938,"twenty":-41.443634,"median":21.065338,"eighty":44.761108,"marketCap":5417434905},{"date":"2022-02-18","current":25.494866,"twenty":-41.443634,"median":21.115412,"eighty":44.761108,"marketCap":5404911676},{"date":"2022-02-25","current":25.29617,"twenty":-41.443634,"median":21.157984,"eighty":44.761108,"marketCap":5362788089},{"date":"2022-03-04","current":23.572347,"twenty":-41.443634,"median":21.240692,"eighty":44.761108,"marketCap":4997337504},{"date":"2022-03-11","current":23.66901,"twenty":-41.443634,"median":21.332705,"eighty":44.761108,"marketCap":5017830061},{"date":"2022-03-18","current":25.352557,"twenty":-41.443634,"median":21.402701,"eighty":44.761108,"marketCap":5374742080},{"date":"2022-03-25","current":26.448071,"twenty":-41.443634,"median":21.507199,"eighty":44.761108,"marketCap":5606991049},{"date":"2022-04-01","current":26.544734,"twenty":-41.443634,"median":21.611248,"eighty":44.761108,"marketCap":5627483605},{"date":"2022-04-08","current":26.703154,"twenty":-41.443634,"median":21.681627,"eighty":44.761108,"marketCap":5661068628},{"date":"2022-04-14","current":28.520955,"twenty":-41.443634,"median":21.86021,"eighty":44.761108,"marketCap":6046442530},{"date":"2022-04-22","current":27.734226,"twenty":-41.443634,"median":22.114023,"eighty":44.761108,"marketCap":5879655893},{"date":"2022-04-29","current":5.98168,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5724467780},{"date":"2022-05-06","current":5.79477,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5545595204},{"date":"2022-05-13","current":5.627805,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5385809640},{"date":"2022-05-20","current":5.695617,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5450705483},{"date":"2022-05-27","current":6.155649,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5890955748},{"date":"2022-06-03","current":6.053281,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5792989652},{"date":"2022-06-10","current":5.809521,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5559711268},{"date":"2022-06-17","current":5.398352,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5166223136},{"date":"2022-06-24","current":5.835537,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5584608729},{"date":"2022-07-01","current":5.86325,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5611129938},{"date":"2022-07-08","current":5.737128,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5490431377},{"date":"2022-07-15","current":5.58499,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5344835356},{"date":"2022-07-22","current":5.922634,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5667961098},{"date":"2022-07-29","current":5.951187,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5439385116},{"date":"2022-08-05","current":6.14725,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5618586516},{"date":"2022-08-12","current":6.304219,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5762055916},{"date":"2022-08-19","current":6.275787,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5736069006},{"date":"2022-08-26","current":6.098679,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5574192212},{"date":"2022-09-02","current":5.884253,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5378207598},{"date":"2022-09-09","current":6.054846,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5534129059},{"date":"2022-09-16","current":5.848121,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5345182567},{"date":"2022-09-23","current":5.752755,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5258018139},{"date":"2022-09-30","current":5.625403,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5141618438},{"date":"2022-10-07","current":5.617703,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5134580316},{"date":"2022-10-14","current":5.641396,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5156236075},{"date":"2022-10-21","current":5.922755,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5413398206},{"date":"2022-10-28","current":6.27401,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5734444824},{"date":"2022-11-04","current":5.909724,"twenty":-41.524262,"median":21.695313,"eighty":44.761658,"marketCap":5401487538},{"date":"2022-11-11","current":6.292902,"twenty":-41.524262,"median":21.556282,"eighty":44.761658,"marketCap":5833519919},{"date":"2022-11-18","current":6.534105,"twenty":-41.524262,"median":9.134384,"eighty":44.761658,"marketCap":6057115624},{"date":"2022-11-25","current":6.524573,"twenty":-41.524262,"median":9.120072,"eighty":44.761658,"marketCap":6048278877},{"date":"2022-12-02","current":6.634386,"twenty":-41.524262,"median":9.077138,"eighty":44.761658,"marketCap":6150076230},{"date":"2022-12-09","current":6.425327,"twenty":-41.524262,"median":9.031818,"eighty":44.761658,"marketCap":5956278049},{"date":"2022-12-16","current":6.216944,"twenty":-41.524262,"median":8.981727,"eighty":44.761658,"marketCap":5763107329},{"date":"2022-12-23","current":6.332842,"twenty":-41.524262,"median":8.929251,"eighty":44.761658,"marketCap":5870544977},{"date":"2022-12-30","current":6.29421,"twenty":-41.524262,"median":8.870812,"eighty":44.761658,"marketCap":5834732428},{"date":"2023-01-06","current":6.238017,"twenty":-41.524262,"median":8.723665,"eighty":44.669031,"marketCap":5782641447},{"date":"2023-01-13","current":6.570492,"twenty":-41.524262,"median":8.558011,"eighty":44.528495,"marketCap":6090846415},{"date":"2023-01-20","current":6.436448,"twenty":-41.524262,"median":8.531792,"eighty":44.433823,"marketCap":5966587722},{"date":"2023-01-27","current":6.301234,"twenty":-41.524262,"median":8.3296,"eighty":44.14834,"marketCap":5841243800},{"date":"2023-02-03","current":6.219087,"twenty":-40.702575,"median":8.3296,"eighty":44.14834,"marketCap":5715340826},{"date":"2023-02-10","current":6.142315,"twenty":-11.558641,"median":8.3296,"eighty":44.14834,"marketCap":5644787763},{"date":"2023-02-17","current":6.10452,"twenty":-11.342294,"median":8.3296,"eighty":44.14834,"marketCap":5610053948},{"date":"2023-02-24","current":6.038378,"twenty":-11.297421,"median":8.3296,"eighty":44.14834,"marketCap":5549269770},{"date":"2023-03-03","current":6.122827,"twenty":-11.1811,"median":8.3296,"eighty":44.14834,"marketCap":5626878140},{"date":"2023-03-10","current":5.75019,"twenty":-11.13773,"median":8.3296,"eighty":44.14834,"marketCap":5284424426},{"date":"2023-03-17","current":5.610229,"twenty":-11.066032,"median":8.3296,"eighty":44.14834,"marketCap":5155800765},{"date":"2023-03-24","current":5.809835,"twenty":-10.976285,"median":8.3296,"eighty":44.14834,"marketCap":5339238729},{"date":"2023-03-31","current":6.065544,"twenty":-10.897567,"median":8.324965,"eighty":44.139273,"marketCap":5574234700},{"date":"2023-04-06","current":5.988772,"twenty":-10.820856,"median":8.324965,"eighty":44.139273,"marketCap":5503681637},{"date":"2023-04-14","current":6.134638,"twenty":-10.775982,"median":8.3296,"eighty":44.14834,"marketCap":5637732457},{"date":"2023-04-21","current":6.151764,"twenty":-10.730374,"median":8.3296,"eighty":44.14834,"marketCap":5653471217},{"date":"2023-04-27","current":5.856489,"twenty":-10.606264,"median":8.340928,"eighty":44.166474,"marketCap":5382113282},{"date":"2023-05-05","current":20.861975,"twenty":-10.43882,"median":8.452838,"eighty":44.175541,"marketCap":4693944269},{"date":"2023-05-12","current":20.287633,"twenty":-10.336151,"median":8.558011,"eighty":44.182524,"marketCap":4564717446},{"date":"2023-05-19","current":21.14158,"twenty":-10.102877,"median":8.693871,"eighty":44.189507,"marketCap":4756855455},{"date":"2023-05-26","current":20.227136,"twenty":-9.78508,"median":8.870812,"eighty":44.196491,"marketCap":4551105489},{"date":"2023-06-02","current":19.892072,"twenty":-9.536436,"median":8.929251,"eighty":44.196491,"marketCap":4475716188},{"date":"2023-06-09","current":20.206194,"twenty":-9.454384,"median":8.98113,"eighty":44.203474,"marketCap":4546393658},{"date":"2023-06-16","current":20.073565,"twenty":-9.376314,"median":9.018699,"eighty":44.210457,"marketCap":4516552059},{"date":"2023-06-23","current":19.475569,"twenty":-9.301666,"median":9.056863,"eighty":44.224123,"marketCap":4382003099},{"date":"2023-06-29","current":19.508145,"twenty":-9.246426,"median":9.092642,"eighty":44.237789,"marketCap":4389332615},{"date":"2023-07-05","current":20.315555,"twenty":-9.193781,"median":9.114705,"eighty":44.251456,"marketCap":4570999888},{"date":"2023-07-14","current":20.455165,"twenty":-9.060547,"median":9.163604,"eighty":44.278788,"marketCap":4602412096},{"date":"2023-07-20","current":21.216038,"twenty":-8.93818,"median":19.183552,"eighty":44.278788,"marketCap":4773608633},{"date":"2023-07-28","current":19.591649,"twenty":4.319692,"median":19.750135,"eighty":44.283744,"marketCap":4682404042},{"date":"2023-08-04","current":19.289348,"twenty":4.38581,"median":19.591649,"eighty":44.129229,"marketCap":4610154209},{"date":"2023-08-11","current":19.13927,"twenty":4.38581,"median":19.482306,"eighty":43.956729,"marketCap":4574285498},{"date":"2023-08-18","current":18.466062,"twenty":4.38581,"median":19.154278,"eighty":43.542383,"marketCap":4413388708},{"date":"2023-08-25","current":18.088722,"twenty":4.38581,"median":18.641868,"eighty":43.319191,"marketCap":4323204519},{"date":"2023-08-31","current":18.781226,"twenty":4.38581,"median":18.466062,"eighty":42.973946,"marketCap":4488713001},{"date":"2023-09-08","current":17.87218,"twenty":4.380867,"median":18.294543,"eighty":42.623722,"marketCap":4271451093},{"date":"2023-09-13","current":17.293307,"twenty":4.378395,"median":18.166977,"eighty":42.388429,"marketCap":4133100350},{"date":"2023-09-22","current":18.005107,"twenty":4.319692,"median":17.86146,"eighty":42.077012,"marketCap":4303220523},{"date":"2023-09-29","current":17.479833,"twenty":4.263461,"median":17.50556,"eighty":41.816324,"marketCap":4177680034},{"date":"2023-10-06","current":17.087485,"twenty":4.263461,"median":17.293307,"eighty":41.73771,"marketCap":4083908975},{"date":"2023-10-13","current":16.418565,"twenty":4.263461,"median":16.945983,"eighty":41.577207,"marketCap":3924037005},{"date":"2023-10-20","current":16.294214,"twenty":4.207231,"median":16.495748,"eighty":41.332109,"marketCap":3894317216},{"date":"2023-10-27","current":16.257767,"twenty":-1.056217,"median":16.28671,"eighty":41.192954,"marketCap":3885606243},{"date":"2023-11-03","current":16.332806,"twenty":-6.207204,"median":16.153784,"eighty":40.948113,"marketCap":3903540598},{"date":"2023-11-10","current":15.616718,"twenty":-6.207204,"median":15.881499,"eighty":40.817223,"marketCap":3732395605},{"date":"2023-11-17","current":16.390693,"twenty":-6.207204,"median":15.574911,"eighty":40.340898,"marketCap":3917375673},{"date":"2023-11-24","current":22.827913,"twenty":-6.207204,"median":15.574911,"eighty":39.96161,"marketCap":4063368468},{"date":"2023-12-01","current":23.015098,"twenty":-8.782697,"median":15.533103,"eighty":39.312288,"marketCap":4096687371},{"date":"2023-12-07","current":23.654406,"twenty":-6.207204,"median":15.574911,"eighty":38.926597,"marketCap":4210484243},{"date":"2023-12-15","current":24.893249,"twenty":-8.782697,"median":15.533103,"eighty":38.72267,"marketCap":4430998377},{"date":"2023-12-22","current":24.325418,"twenty":-8.782697,"median":15.533103,"eighty":38.648421,"marketCap":4329924480},{"date":"2023-12-29","current":24.225549,"twenty":-8.789917,"median":12.47951,"eighty":38.641433,"marketCap":4312147664},{"date":"2024-01-05","current":22.661874,"twenty":-8.797137,"median":9.425916,"eighty":38.597758,"marketCap":4033813516},{"date":"2024-01-12","current":23.423737,"twenty":-8.797137,"median":9.425916,"eighty":38.470225,"marketCap":4169425227},{"date":"2024-01-19","current":22.447867,"twenty":-8.804357,"median":9.30281,"eighty":38.332211,"marketCap":3995720339},{"date":"2024-01-26","current":22.718942,"twenty":-8.797137,"median":9.425916,"eighty":38.217781,"marketCap":4043971696},{"date":"2024-02-02","current":28.85349,"twenty":-8.797137,"median":9.425916,"eighty":38.049194,"marketCap":4731972377},{"date":"2024-02-09","current":27.918791,"twenty":-8.797137,"median":9.425916,"eighty":37.903318,"marketCap":4578681720},{"date":"2024-02-16","current":28.325049,"twenty":-8.797137,"median":9.425916,"eighty":37.631656,"marketCap":4645308051},{"date":"2024-02-23","current":28.413632,"twenty":-8.797137,"median":9.425916,"eighty":37.11978,"marketCap":4659835597},{"date":"2024-03-01","current":28.603015,"twenty":-8.789917,"median":12.47951,"eighty":32.879225,"marketCap":4690894489},{"date":"2024-03-08","current":29.339167,"twenty":-8.789917,"median":12.47951,"eighty":32.536971,"marketCap":4811623405},{"date":"2024-03-15","current":29.363604,"twenty":-8.789917,"median":12.47951,"eighty":32.258469,"marketCap":4815631004},{"date":"2024-03-22","current":29.357495,"twenty":-8.789917,"median":12.47951,"eighty":31.941046,"marketCap":4814629104},{"date":"2024-03-28","current":29.81568,"twenty":-8.789917,"median":12.47951,"eighty":31.40619,"marketCap":4889771583},{"date":"2024-04-05","current":29.122292,"twenty":-8.797137,"median":9.425916,"eighty":31.117622,"marketCap":4776055965},{"date":"2024-04-12","current":29.372767,"twenty":-8.797137,"median":9.425916,"eighty":31.051184,"marketCap":4817133853},{"date":"2024-04-19","current":29.168111,"twenty":-8.797137,"median":9.425916,"eighty":30.606254,"marketCap":4783570213},{"date":"2024-04-26","current":29.079528,"twenty":-8.789917,"median":12.47951,"eighty":30.256618,"marketCap":4769042667},{"date":"2024-05-03","current":24.879315,"twenty":-8.789917,"median":12.47951,"eighty":29.945905,"marketCap":4801707860},{"date":"2024-05-10","current":25.416952,"twenty":-8.789917,"median":12.47951,"eighty":29.757033,"marketCap":4905471669},{"date":"2024-05-17","current":25.614345,"twenty":-8.789917,"median":12.47951,"eighty":29.613467,"marketCap":4943568527},{"date":"2024-05-24","current":25.463703,"twenty":-8.789917,"median":12.47951,"eighty":29.5169,"marketCap":4914494609},{"date":"2024-05-31","current":25.87667,"twenty":-8.789917,"median":12.47951,"eighty":29.365437,"marketCap":4994197245},{"date":"2024-06-07","current":26.035104,"twenty":-8.789917,"median":12.47951,"eighty":29.342276,"marketCap":5024774986},{"date":"2024-06-14","current":25.292282,"twenty":-8.797137,"median":9.425916,"eighty":29.274986,"marketCap":4881410496},{"date":"2024-06-21","current":25.066319,"twenty":-8.804357,"median":9.30281,"eighty":29.230424,"marketCap":4837799620},{"date":"2024-06-28","current":24.487127,"twenty":-8.826676,"median":9.172548,"eighty":29.168722,"marketCap":4726015420},{"date":"2024-07-05","current":24.193634,"twenty":-8.826676,"median":9.172548,"eighty":29.132067,"marketCap":4669371408},{"date":"2024-07-12","current":24.601407,"twenty":-8.826676,"median":9.172548,"eighty":29.097856,"marketCap":4748071495},{"date":"2024-07-15","current":24.596212,"twenty":-8.826676,"median":9.172548,"eighty":29.090525,"marketCap":4747068946},{"date":"2024-08-02","current":24.957234,"twenty":-8.929025,"median":9.114705,"eighty":28.735731,"marketCap":4816746093},{"date":"2024-08-09","current":27.237695,"twenty":-8.929025,"median":9.114705,"eighty":28.677936,"marketCap":4058416549},{"date":"2024-08-16","current":27.91282,"twenty":-8.929025,"median":9.114705,"eighty":28.593851,"marketCap":4159010197},{"date":"2024-08-23","current":28.407693,"twenty":-8.929025,"median":9.114705,"eighty":28.535286,"marketCap":4232746318},{"date":"2024-08-30","current":29.413827,"twenty":-8.929025,"median":9.114705,"eighty":28.535286,"marketCap":4382660153},{"date":"2024-09-06","current":28.273324,"twenty":-8.929025,"median":9.114705,"eighty":28.515633,"marketCap":4212725252},{"date":"2024-09-13","current":27.91282,"twenty":-8.929025,"median":9.114705,"eighty":28.437936,"marketCap":4159010197},{"date":"2024-09-20","current":28.840298,"twenty":-8.929025,"median":9.114705,"eighty":28.414125,"marketCap":4297204384},{"date":"2024-09-27","current":28.584668,"twenty":-8.929025,"median":9.114705,"eighty":28.410315,"marketCap":4259115526},{"date":"2024-10-04","current":27.693241,"twenty":-8.929025,"median":9.114705,"eighty":28.328952,"marketCap":4126292846},{"date":"2024-10-11","current":27.781728,"twenty":-8.929025,"median":9.114705,"eighty":28.174035,"marketCap":4139477450},{"date":"2024-10-18","current":28.768197,"twenty":-8.929025,"median":9.114705,"eighty":28.155826,"marketCap":4286461373},{"date":"2024-10-25","current":27.847274,"twenty":-8.929025,"median":9.114705,"eighty":28.143107,"marketCap":4149243823},{"date":"2024-10-31","current":28.55845,"twenty":-8.929025,"median":9.114705,"eighty":28.102675,"marketCap":4255208977},{"date":"2024-11-08","current":23.317939,"twenty":-8.93818,"median":9.109339,"eighty":27.987673,"marketCap":3940731747},{"date":"2024-11-15","current":22.552233,"twenty":-8.93818,"median":9.109339,"eighty":27.96198,"marketCap":3811327297},{"date":"2024-11-22","current":21.642415,"twenty":-8.93818,"median":9.127228,"eighty":27.96083,"marketCap":3657568070},{"date":"2024-11-29","current":21.759491,"twenty":-8.93818,"median":9.172548,"eighty":27.96083,"marketCap":3677353987},{"date":"2024-12-06","current":21.310698,"twenty":-8.93818,"median":16.14628,"eighty":27.96083,"marketCap":3601507972},{"date":"2024-12-13","current":20.66399,"twenty":-8.93818,"median":16.326374,"eighty":27.96083,"marketCap":3492214336},{"date":"2024-12-20","current":20.056308,"twenty":-8.93818,"median":16.418565,"eighty":27.96083,"marketCap":3389516005},{"date":"2024-12-27","current":20.109271,"twenty":-8.93818,"median":16.564355,"eighty":27.96083,"marketCap":3398466777},{"date":"2025-01-03","current":19.440263,"twenty":-8.93818,"median":16.920255,"eighty":27.96083,"marketCap":3285404395},{"date":"2025-01-10","current":19.6399,"twenty":-8.938327,"median":17.089629,"eighty":27.96106,"marketCap":3319143109},{"date":"2025-01-17","current":19.75157,"twenty":-8.938327,"median":17.49484,"eighty":27.96106,"marketCap":3338015281},{"date":"2025-01-24","current":20.086579,"twenty":-8.938327,"median":17.759622,"eighty":27.96106,"marketCap":3394631794},{"date":"2025-01-31","current":-136.701619,"twenty":-9.032373,"median":17.86146,"eighty":27.96106,"marketCap":3007435623},{"date":"2025-02-07","current":-139.725612,"twenty":-9.144874,"median":17.86146,"eighty":27.96106,"marketCap":3073963459},{"date":"2025-02-14","current":-139.361017,"twenty":-9.245709,"median":17.86146,"eighty":27.96106,"marketCap":3065942372},{"date":"2025-02-21","current":-140.326121,"twenty":-9.301666,"median":17.86146,"eighty":27.96106,"marketCap":3087174660},{"date":"2025-02-28","current":-131.897546,"twenty":-9.377985,"median":17.86146,"eighty":27.96106,"marketCap":2901746013},{"date":"2025-03-07","current":-127.90845,"twenty":-9.455107,"median":17.87218,"eighty":27.96129,"marketCap":2813985889},{"date":"2025-03-14","current":-119.994597,"twenty":-9.579026,"median":17.87218,"eighty":27.96129,"marketCap":2639881128},{"date":"2025-03-21","current":-119.823023,"twenty":-9.954842,"median":17.87218,"eighty":27.96129,"marketCap":2636106499},{"date":"2025-03-28","current":-128.144364,"twenty":-10.210799,"median":17.87218,"eighty":27.96129,"marketCap":2819176004},{"date":"2025-04-04","current":-113.839378,"twenty":-10.377935,"median":17.87218,"eighty":27.96129,"marketCap":2504466314},{"date":"2025-04-11","current":-104.209785,"twenty":-10.499986,"median":17.86146,"eighty":27.96106,"marketCap":2292615264},{"date":"2025-04-17","current":-106.268673,"twenty":-10.617545,"median":17.86146,"eighty":27.96106,"marketCap":2337910812},{"date":"2025-04-25","current":-114.482781,"twenty":-10.734618,"median":17.87218,"eighty":27.96129,"marketCap":2518621173},{"date":"2025-05-02","current":-19.826576,"twenty":-10.796539,"median":17.87218,"eighty":27.96129,"marketCap":2240403051},{"date":"2025-05-09","current":-20.214777,"twenty":-10.804561,"median":17.87218,"eighty":27.96129,"marketCap":2284269804},{"date":"2025-05-16","current":-20.890086,"twenty":-10.804561,"median":17.87218,"eighty":27.96129,"marketCap":2360579678},{"date":"2025-05-23","current":-20.234996,"twenty":-10.804561,"median":17.87218,"eighty":27.96129,"marketCap":2286554531},{"date":"2025-05-30","current":-20.590847,"twenty":-10.804561,"median":17.87218,"eighty":27.96129,"marketCap":2326765722},{"date":"2025-06-06","current":-20.040895,"twenty":-10.804561,"median":17.87218,"eighty":27.96129,"marketCap":2264621154},{"date":"2025-06-13","current":-20.894129,"twenty":-10.804561,"median":17.87218,"eighty":27.96129,"marketCap":2361036623},{"date":"2025-06-20","current":-19.676956,"twenty":-10.798043,"median":17.87218,"eighty":27.96152,"marketCap":2223496073},{"date":"2025-06-27","current":-20.627241,"twenty":-10.798043,"median":17.87218,"eighty":27.96152,"marketCap":2330878230},{"date":"2025-07-03","current":-21.706926,"twenty":-10.798043,"median":17.87218,"eighty":27.96152,"marketCap":2452882638},{"date":"2025-07-11","current":-22.026383,"twenty":-10.798043,"median":17.87218,"eighty":27.96152,"marketCap":2488981321},{"date":"2025-07-18","current":-21.18528,"twenty":-10.798043,"median":17.87218,"eighty":27.96152,"marketCap":2393936688},{"date":"2025-07-25","current":-20.505928,"twenty":-10.798043,"median":17.87218,"eighty":27.96152,"marketCap":2317169869},{"date":"2025-08-01","current":-2.737049,"twenty":-10.76094,"median":17.87218,"eighty":27.96152,"marketCap":2356599194},{"date":"2025-08-08","current":-2.80022,"twenty":-10.723337,"median":17.87218,"eighty":27.96152,"marketCap":2410989284},{"date":"2025-08-15","current":-2.870292,"twenty":-10.566654,"median":17.87218,"eighty":27.96152,"marketCap":2471321149},{"date":"2025-08-22","current":-2.860736,"twenty":-10.421629,"median":17.87218,"eighty":27.96152,"marketCap":2463094076},{"date":"2025-08-29","current":-3.004596,"twenty":-10.277414,"median":17.87218,"eighty":27.96152,"marketCap":2586957222},{"date":"2025-09-05","current":-2.879316,"twenty":-10.005461,"median":17.87218,"eighty":27.96175,"marketCap":2479091161},{"date":"2025-09-12","current":-2.903204,"twenty":-9.719819,"median":17.87218,"eighty":27.96152,"marketCap":2499658843},{"date":"2025-09-19","current":-2.749789,"twenty":-9.45821,"median":17.87218,"eighty":27.96152,"marketCap":2367568624},{"date":"2025-09-26","current":-2.542228,"twenty":-9.436498,"median":17.87218,"eighty":27.96152,"marketCap":2188858328},{"date":"2025-10-03","current":-2.576733,"twenty":-9.32689,"median":17.87218,"eighty":27.96152,"marketCap":2218567201},{"date":"2025-10-10","current":-2.57461,"twenty":-9.261764,"median":17.87218,"eighty":27.96152,"marketCap":2216738963},{"date":"2025-10-17","current":-2.597967,"twenty":-9.173249,"median":17.87218,"eighty":27.96152,"marketCap":2236849584},{"date":"2025-10-24","current":-2.647336,"twenty":-9.074857,"median":17.87218,"eighty":27.96152,"marketCap":2279356125},{"date":"2025-10-31","current":-2.583634,"twenty":-8.91987,"median":17.87218,"eighty":27.96152,"marketCap":2224508975},{"date":"2025-11-07","current":-2.720181,"twenty":-3.003747,"median":17.87218,"eighty":27.96152,"marketCap":2298552627},{"date":"2025-11-14","current":-2.872173,"twenty":-2.952467,"median":17.87218,"eighty":27.96152,"marketCap":2426986369},{"date":"2025-11-21","current":-2.606744,"twenty":-2.890145,"median":17.87218,"eighty":27.96152,"marketCap":2202698684},{"date":"2025-11-28","current":-2.862116,"twenty":-2.871421,"median":17.87218,"eighty":27.96152,"marketCap":2418488177},{"date":"2025-12-05","current":-3.153738,"twenty":-2.870292,"median":17.87218,"eighty":27.96152,"marketCap":2664908806},{"date":"2025-12-12","current":-3.279801,"twenty":-2.870292,"median":17.87218,"eighty":27.96152,"marketCap":2771432010},{"date":"2025-12-19","current":-3.20676,"twenty":-2.870292,"median":17.87218,"eighty":27.96152,"marketCap":2709712557},{"date":"2025-12-26","current":-3.213253,"twenty":-2.870292,"median":17.87218,"eighty":27.96152,"marketCap":2715198731},{"date":"2026-01-02","current":-3.177352,"twenty":-2.870292,"median":17.87218,"eighty":27.96152,"marketCap":2684862348},{"date":"2026-01-09","current":-3.244506,"twenty":-2.870292,"median":17.87218,"eighty":27.96152,"marketCap":2741607351},{"date":"2026-01-16","current":-3.475212,"twenty":-2.870292,"median":17.87218,"eighty":27.96152,"marketCap":2936553892},{"date":"2026-01-23","current":-3.416723,"twenty":-2.870292,"median":17.87218,"eighty":27.96152,"marketCap":2887130825},{"date":"2026-01-30","current":-3.34307,"twenty":-2.870292,"median":17.87218,"eighty":27.96152,"marketCap":2824894371},{"date":"2026-02-06","current":-4.1748,"twenty":-2.870292,"median":17.87218,"eighty":27.96152,"marketCap":2888961309},{"date":"2026-02-13","current":-4.035926,"twenty":-2.870292,"median":17.87218,"eighty":27.96152,"marketCap":2792860901},{"date":"2026-02-20","current":-4.180751,"twenty":-2.870292,"median":17.87218,"eighty":27.96152,"marketCap":2893079898},{"date":"2026-02-27","current":-4.117928,"twenty":-2.870292,"median":17.87218,"eighty":27.96152,"marketCap":2849605904},{"date":"2026-03-06","current":-3.79389,"twenty":-2.870292,"median":17.87218,"eighty":27.96152,"marketCap":2625371619},{"date":"2026-03-13","current":-3.371318,"twenty":-2.870292,"median":17.87218,"eighty":27.96152,"marketCap":2332951807},{"date":"2026-03-20","current":-3.319075,"twenty":-2.870292,"median":17.87218,"eighty":27.96152,"marketCap":2296799748},{"date":"2026-03-23","current":-3.227815,"twenty":-2.870292,"median":17.87218,"eighty":27.96152,"marketCap":2233648052}],"updateTime":1774398426411},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ASH\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2621867190","title":"Assessing Ashland (ASH) Valuation After Recent Share Price Weakness And Perceived 27.3% Discount","url":"https://stock-news.laohu8.com/highlight/detail?id=2621867190","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621867190?lang=en_us&edition=fundamental","pubTime":"2026-03-24 02:09","pubTimestamp":1774289353,"startTime":"0","endTime":"0","summary":"Context for Ashland after recent share price moves\nAshland (ASH) has come back into focus for investors after a period of weaker share performance, with the stock showing declines over the past month, past 3 months, year to date, and over the past year.\nSee our latest analysis for Ashland.\nAt a share price of $48.81, Ashland’s recent 1 month share price return of 24.68% and 3 year total shareholder return of 47.02% point to pressure on sentiment rather than building momentum.\nIf Ashland’s...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/2024000-choice2-main-header/1585186739035","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2024000-choice2-main-header/1585186739035"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/materials/nyse-ash/ashland/news/assessing-ashland-ash-valuation-after-recent-share-price-wea-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/materials/nyse-ash/ashland/news/assessing-ashland-ash-valuation-after-recent-share-price-wea-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7057","BK4109","ASH.AU","ASH","LU2463526074.USD"],"gpt_icon":0},{"id":"2621017567","title":"Ashland Is Maintained at Buy by Argus Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2621017567","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621017567?lang=en_us&edition=fundamental","pubTime":"2026-03-23 22:08","pubTimestamp":1774274880,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ASH/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 23, 2026 10:08 ET (14:08 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASH"],"gpt_icon":0},{"id":"2621770834","title":"Ashland Inc : Argus Research Cuts Target Price to $56 From $70","url":"https://stock-news.laohu8.com/highlight/detail?id=2621770834","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621770834?lang=en_us&edition=fundamental","pubTime":"2026-03-23 19:41","pubTimestamp":1774266068,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nFWN40B0K5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4109","ASH","LU2463526074.USD"],"gpt_icon":0},{"id":"2621706717","title":"Ashland Implements Pricing Actions Globally Due to Market Volatility Amid Middle East Conflict","url":"https://stock-news.laohu8.com/highlight/detail?id=2621706717","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621706717?lang=en_us&edition=fundamental","pubTime":"2026-03-23 19:20","pubTimestamp":1774264827,"startTime":"0","endTime":"0","summary":"Ashland (ASH) said Monday it is implementing pricing actions across its product portfolios in Life Sciences, Intermediates, Personal Care and Specialty Additives due to market volatility brought by the Middle East conflict.Pricing actions will vary by product and region, the company said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ASH","ASH.AU","LU2463526074.USD","BK7057","BK4109"],"gpt_icon":0},{"id":"2621777744","title":"Ashland to implement global pricing actions across product portfolio to manage energy, raw material and logistics volatility","url":"https://stock-news.laohu8.com/highlight/detail?id=2621777744","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621777744?lang=en_us&edition=fundamental","pubTime":"2026-03-23 19:00","pubTimestamp":1774263604,"startTime":"0","endTime":"0","summary":"Ashland plans to implement pricing actions across its Life Sciences, Intermediates, Personal Care and Specialty Additives portfolios globally in response to volatility in energy markets, raw material costs and logistics conditions.Actions are expected to vary by product and region based on local market dynamics, contractual terms and individual customer requirements.The company intends to take additional steps across procurement, supply chain and operations to manage costs where possible while maintaining supply to customers.Ashland plans to monitor market conditions and adjust pricing and related actions as market dynamics evolve.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ashland Inc. published the original content used to genera","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDL3JNwB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASH","BK4109","LU2463526074.USD"],"gpt_icon":0},{"id":"2621772207","title":"Press Release: BioLineRx Reports 2025 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2621772207","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621772207?lang=en_us&edition=fundamental","pubTime":"2026-03-23 19:00","pubTimestamp":1774263600,"startTime":"0","endTime":"0","summary":"- On track to initiate Phase 1/2a clinical trial of GLIX1 for treatment of glioblastoma  by end of this month -. - GLIX1 is positioned to potentially address unmet needs for novel and more effective cancer treatments by targeting DNA damage response mechanisms -. - Management to host conference call today, March 23, at 8:30 am EDT -. TEL AVIV, Israel, March 23, 2026 /PRNewswire/ -- BioLineRx Ltd.  , a development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today reported its audited financial results for the year ended December 31, 2025, and provided a corporate update.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLRX","PFS","BK4567","LU2211817866.USD","IE00BYQQ9H92.USD","ASH","MTD","BK4211","BK4533","LU2413666426.HKD","SCD","IE00BFXG0V08.USD","BK4109","BK4195","LU2413666699.HKD","LU0347712357.USD","BK4585","LU2463526074.USD","LU1721428933.USD","BK4588","BK4121","LU1093756325.SGD","IE00B5TLWC47.USD","BK4139","BK4548","LU1093756168.USD"],"gpt_icon":0},{"id":"2621777612","title":"Ashland Inc - Pricing Actions to Vary by Product and Region","url":"https://stock-news.laohu8.com/highlight/detail?id=2621777612","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621777612?lang=en_us&edition=fundamental","pubTime":"2026-03-23 18:55","pubTimestamp":1774263310,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nFWN40B0GU:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2463526074.USD","ASH","BK4109"],"gpt_icon":0},{"id":"2621477761","title":"Ashland Implements Pricing Actions Across Product Portfolio in Response to Market Volatility","url":"https://stock-news.laohu8.com/highlight/detail?id=2621477761","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621477761?lang=en_us&edition=fundamental","pubTime":"2026-03-23 18:55","pubTimestamp":1774263310,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nFWN40B0GU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2463526074.USD","ASH","BK4109"],"gpt_icon":0},{"id":"2620779332","title":"Cellectis Reports Full Year 2025 Financial Results and Provides a Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2620779332","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620779332?lang=en_us&edition=fundamental","pubTime":"2026-03-20 07:21","pubTimestamp":1773962460,"startTime":"0","endTime":"0","summary":"Pivotal Phase 2 with lasme-cel in r/r B-ALL (BALLI-01 trial) ongoing Phase 1: 83% ORR at RP2D and 100% ORR in the target Phase 2 populationIn target Phase 2 population: 100% of patients became eligibl","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/19/3259513/0/en/Cellectis-Reports-Full-Year-2025-Financial-Results-and-Provides-a-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4097","BK4109","BK4187","CLLS","IE00B7SZL793.SGD","LU2463526074.USD","OS","ASH","BK4006","IE00B19Z4B17.USD","IE00B66KJ199.SGD","LU0963586101.USD","BK4139","CRS","ORR","IE0031619046.USD","LU2065731478.USD"],"gpt_icon":0},{"id":"2620527648","title":"Press Release: SELLAS Life Sciences Reports Full Year 2025 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2620527648","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620527648?lang=en_us&edition=fundamental","pubTime":"2026-03-20 04:05","pubTimestamp":1773950700,"startTime":"0","endTime":"0","summary":"-- Continued Advancement of Pivotal Phase 3 REGAL Trial of Galinpepimut-S  in Acute Myeloid Leukemia  - Final Analysis upon Reaching 80 Events --. -- First Patient Dosed in Phase 2 Trial of SLS009 in Newly Diagnosed First Line AML --. -- $71.8 Million in Cash and Cash Equivalents as of December 31, 2025; Additional $42.6 Million in Proceeds Received in Q1 2026 to Date Through Warrant Exercises --. NEW YORK, March 19, 2026  -- SELLAS Life Sciences Group, Inc.  , a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today reported financial results for the full year ended December 31, 2025, and provided a corporate update.European Collaboration to Advance SLS009 Clinical Program: In January 2026, SELLAS entered into a strategic collaboration with IMPACT-AML to expand SLS009 clinical program in Europe. Under the agreement, IMPACT-AML's STREAM clinical network will conduct a study of SLS009 in combination with","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2463526074.USD","SLS","ASH","BK4109","BK4139"],"gpt_icon":0},{"id":"2620896241","title":"Belief BioMed announced BBM-H901 (Dalnacogene Ponparvovec Injection), China's first hemophilia B gene therapy, was officially approved in Macao, China","url":"https://stock-news.laohu8.com/highlight/detail?id=2620896241","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620896241?lang=en_us&edition=fundamental","pubTime":"2026-03-19 18:27","pubTimestamp":1773916020,"startTime":"0","endTime":"0","summary":"SHANGHAI, March 19, 2026 /PRNewswire/ -- Belief BioMed  today announced that BBM-H901 , has been officially approved by the Pharmaceutical Administration Bureau of Macao Special Administrative Region of China for the treatment of adult patients with moderate to severe hemophilia B . This product is developed and manufactured by BBM, and Takeda China is responsible for its commercialization in mainland China, Hong Kong, China and Macao, China. Following its approval in mainland China in April 2025 as the country's first gene therapy for hemophilia B, [1] the recent approval of BBM-H901 in Macao, China, not only addresses the previously unmet medical need for such treatment in the region but also marks a crucial step in accelerating the global availability of this breakthrough gene therapy.BBM-H901 is a gene therapy drug based on a recombinant adeno-associated virus  vector. It can precisely deliver the high-activity FIX gene into the liver cells of patients, enabling the sustained and h","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/belief-biomed-announced-bbm-h901-dalnacogene-ponparvovec-injection-chinas-first-hemophilia-b-gene-therapy-was-officially-approved-in-macao-china-302718633.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4081","EMA.AU","BK7504","IE0009354923.USD","ASH","LU0054578231.USD","BK4183","FIX","ATMP","BK7095","BK7057","ABR","LU0053671581.USD","BK4567","BK4110","EMA","ASH.AU","BK4109","BK4129","BLA.AU","BK7129","ODD","ABR.AU","LU0963586101.USD","LU2463526074.USD"],"gpt_icon":0},{"id":"2620429837","title":"Press Release: Marker Therapeutics Reports Year-End 2025 Corporate and Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2620429837","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620429837?lang=en_us&edition=fundamental","pubTime":"2026-03-19 05:31","pubTimestamp":1773869460,"startTime":"0","endTime":"0","summary":"Phase 1 APOLLO data update demonstrated encouraging clinical activity with a 66% objective response rate in relapsed non-Hodgkin lymphoma, including 50% complete responses. Research published in Nature Medicine highlighted promising results of multi-antigen targeted T cells in pancreatic cancer. Strengthened manufacturing capabilities through collaboration with Cellipont Bioservices and expanded Board of Directors with appointment of Kathryn Penkus Corzo. HOUSTON, March 18, 2026  -- Marker Therapeutics, Inc. , a clinical-stage immuno-oncology company developing next-generation T cell-based immunotherapies for hematological malignancies and solid tumors, today announced corporate updates and financial results for the year ended December 31, 2025.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRKR","BK4007","BK4109","NCI","IE00B1G9WX41.USD","BK4139","BK4142","LENZ","GB00B4LPDJ14.GBP","BK4585","LU0690374961.EUR","LU2404859741.USD","LU2404859667.USD","IE00B0T0GQ85.USD","LU2463526074.USD","LU1718418525.SGD","IE00B95QR487.USD","IE00BD0PCF45.HKD","GB00B4QBRK32.GBP","ASH","MAR","BK4588","BK4539","BK4202","LU0690374615.EUR","IE00B45NX917.SGD"],"gpt_icon":0},{"id":"2620874405","title":"Ashland CFO William Whitaker to join fireside chat at Gabelli Funds Specialty Chemicals Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2620874405","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620874405?lang=en_us&edition=fundamental","pubTime":"2026-03-18 05:01","pubTimestamp":1773781285,"startTime":"0","endTime":"0","summary":"Ashland CFO William Whitaker will participate in a fireside chat at the Gabelli Funds’ 17th Annual Specialty Chemicals Symposium on March 19, 2026 at 1:30 p.m. ET. Whitaker is also scheduled to hold one-on-one meetings with institutional investors during the event on March 19, 2026. The live webcast registration is available at .","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDL3WY6x0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","GAMI","IE00BN0W2W23.USD","IE00BGHQF748.EUR","LU2210149790.SGD","SG9999014005.SGD","IE00BKPKM429.USD","LU2095319765.USD","LU2463526074.USD","BK4585","SG9999014039.USD","BK4109","NDAQ","BK4135","SG9999014021.USD","LU2210150020.SGD","IE00BN0W2V16.EUR","SG9999014013.SGD","ASH","IE00BN0W2T93.GBP","LU0314104364.USD","IE00B3QW5Z07.USD","BK4112","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2620324476","title":"Ashland (ASH) Is Down 7.7% After Tightening 2026 Outlook And Detailing New Cost Savings Targets","url":"https://stock-news.laohu8.com/highlight/detail?id=2620324476","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620324476?lang=en_us&edition=fundamental","pubTime":"2026-03-17 22:16","pubTimestamp":1773756960,"startTime":"0","endTime":"0","summary":"Ashland recently reported past growth in its Life Sciences revenue and adjusted EBITDA, narrowed its FY2026 adjusted EBITDA outlook to US$400 million–US$420 million, and outlined roughly US$30 million of expected FY2026 savings from a broader US$90 million manufacturing optimization program.\nDespite headwinds from a facility outage and asbestos litigation reserves, Ashland emphasized a strong balance sheet and plans for double-digit-plus adjusted EPS growth, underscoring how cost initiatives...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/2024000-choice2-main-header/1585186739035","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2024000-choice2-main-header/1585186739035"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/materials/nyse-ash/ashland/news/ashland-ash-is-down-77-after-tightening-2026-outlook-and-det","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/materials/nyse-ash/ashland/news/ashland-ash-is-down-77-after-tightening-2026-outlook-and-det","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4109","ASH","BK7057","LU2463526074.USD","ASH.AU"],"gpt_icon":0},{"id":"2619520971","title":"Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2619520971","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619520971?lang=en_us&edition=fundamental","pubTime":"2026-03-13 04:01","pubTimestamp":1773345660,"startTime":"0","endTime":"0","summary":"Announced data from cohort 4 of soquelitinib atopic dermatitis Phase 1 trial demonstrating positive safety and efficacy results, including in patients who have received prior systemic therapy Initiate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/12/3255077/0/en/Corvus-Pharmaceuticals-Provides-Business-Update-and-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVS","ALPS","BK4139","BK4109","ASH","BK4213","SID","BK4568","LU2463526074.USD","BK4006"],"gpt_icon":0},{"id":"2619215207","title":"Molecular Partners Reports Highlights and Financial Results for Full Year 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2619215207","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619215207?lang=en_us&edition=fundamental","pubTime":"2026-03-13 04:00","pubTimestamp":1773345600,"startTime":"0","endTime":"0","summary":"Initiated US Phase 1/2a study of DLL3-targeting 212Pb-based Radio-DARPin candidate MP0712 for SCLC and other neuroendocrine cancers, co-developed with strategic partner Orano Med; initial data anticip","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/12/3255073/0/en/Molecular-Partners-Reports-Highlights-and-Financial-Results-for-Full-Year-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4108","IE00BMG7P926.USD","BK4509","BK4563","IE00BMG7P694.USD","LU0359201612.USD","IE00BMG7P819.SGD","BK4144","LU1023057109.AUD","BK4080","TRP","BK4539","LU2463526074.USD","BK4531","BK4571","IE00BMG7P702.HKD","BK4109","BK4552","BK4535","BK4565","BK4566","IE00BD4GTW91.USD","LU0456842615.SGD","LU0359202008.SGD","IE00BYQNZ168.SGD","IE00BYTNYN87.SGD","SITC","BK4139","TME","IE00BD4GTT62.SGD","ASH","01698","BK4231","BK4548","BK4526","IE00BMG7P587.USD","IE00BD4GTV84.USD","LU2039709279.SGD","MOLN","LU0509642566.USD","LU0828238088.HKD","LU0269904917.USD","IE00B12V2V27.USD","SG9999011746.SGD"],"gpt_icon":0},{"id":"2618934912","title":"Press Release: Prelude Therapeutics Reports Full Year 2025 Financial Results and Provides Program Outlook for 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2618934912","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618934912?lang=en_us&edition=fundamental","pubTime":"2026-03-10 19:01","pubTimestamp":1773140460,"startTime":"0","endTime":"0","summary":"Received FDA clearance of Investigational New Drug application  for PRT12396, mutant-selective JAK2V617F inhibitor in the first quarter of 2026. Phase 1 study of PRT12396 in patients with polycythemia vera and myelofibrosis anticipated to initiate by Q2 2026. Preclinical development and IND enabling studies for PRT13722, highly-selective oral KAT6A degrader underway, and the Company intends to file the IND for PRT13722 in mid-2026 with Phase 1 study initiation anticipated in the 2 half of 2026. Current cash runway expected into second quarter of 2027 with $106 million in cash, cash equivalents, restricted cash and marketable securities as of December 31, 2025. The Phase 1 study of PRT12396 is an open-label, multi-center study in patients with high-risk PV and intermediate and high-risk MF.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ET","BK4581","BK4109","PRLD","ASH","LU2463526074.USD","IND","BK4588","BK4139","BK4505","BK4590","BK4561","BK4585","BK4144"],"gpt_icon":0},{"id":"2618934291","title":"Legend Biotech Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2618934291","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618934291?lang=en_us&edition=fundamental","pubTime":"2026-03-10 19:00","pubTimestamp":1773140400,"startTime":"0","endTime":"0","summary":"CARVYKTI (ciltacabtagene autoleucel; cilta-cel) net trade sales of approximately $555 million and $1.9 billion for the fourth quarter and full year 2025, respectivelySurpassed milestone of more than 1","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/10/3252614/0/en/Legend-Biotech-Reports-Fourth-Quarter-and-Full-Year-2025-Results-and-Recent-Highlights.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4109","BK4588","LU2463526074.USD","BK4139","BK4505","XBI","BK4585","BK4581","LEGN","ASH"],"gpt_icon":0},{"id":"2617411075","title":"Press Release: Climb Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2617411075","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617411075?lang=en_us&edition=fundamental","pubTime":"2026-03-05 20:00","pubTimestamp":1772712000,"startTime":"0","endTime":"0","summary":"Dosing completed in Phase 1 study of budoprutug subcutaneous formulation, with data expected in H1 2026. Budoprutug clinical trials ongoing in pMN, ITP, and SLE, with initial data from all three trials expected in H2 2026. Enrollment ongoing in CLYM116 Phase 1 healthy volunteer study, with initial data expected mid-2026. WELLESLEY HILLS, Mass., March 05, 2026  -- Climb Bio, Inc. , a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today reported financial results for the fourth quarter and full year ended December 31, 2025, and provided business updates.previously treated patients with ITP is designed to evaluate safety,","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND","BK4539","BK4109","ITP","SLE","ASH","BK4139","BK4199","CLYM","LU2463526074.USD","BK4077"],"gpt_icon":0},{"id":"2616253758","title":"TScan Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2616253758","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616253758?lang=en_us&edition=fundamental","pubTime":"2026-03-04 20:00","pubTimestamp":1772625600,"startTime":"0","endTime":"0","summary":"Presented positive updated data from the ALLOHA Phase 1 heme trial at 67th American Society of Hematology (ASH) Annual Meeting and Exposition Announced completion of enrollment in Cohort C of Phase 1 ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/04/3249222/0/en/TScan-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4109","BK4539","BK4007","LU2463526074.USD","IND","BK4139","ASH"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":198,"code":"91000000","status":"200"}]}}